Soluble Glycoprotein V For Treating Thrombotic Diseases


The full document isn't yet available to us from the patent office.


A soluble polypeptide comprising a modified glycoprotein V (GPV) for use in the treatment or prevention of a thrombotic disease in a subject, said treatment or prevention comprising administering to the subject an effective amount of said soluble polypeptide.


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jun 28, 2017
  • Application: Dec 23, 2015
    EP EP 15202530 A
  • Priority: Dec 23, 2015
    EP EP 15202530 A

Download Citation

Sign in to the Lens